| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 1,302,100 | 1,379,500 | 1,604,400 | 1,569,100 | | Cost of Revenue | 874,700 | 911,900 | 1,105,500 | 1,106,900 | | | Gross Profit | 427,400 | 467,600 | 498,900 | 462,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 90,400 | 97,900 | 99,700 | 91,000 | | Non Recurring |
-
|
-
|
-
| 11,800 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 337,000 | 369,700 | 399,200 | 359,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 900 | 800 | 800 | 2,400 | | Earnings Before Interest And Taxes | 337,900 | 370,500 | 400,000 | 361,800 | | Interest Expense | 3,600 | 4,400 | 4,200 | 4,400 | | Income Before Tax | 334,300 | 366,100 | 395,800 | 357,400 | | Income Tax Expense | 116,000 | 125,900 | 132,900 | 122,800 | | Minority Interest | (100) | (100) | 100 | (100) | | | | Net Income From Continuing Ops | 218,400 | 240,100 | 263,000 | 234,500 | | | Non-recurring Events | | Discontinued Operations |
-
| 300 | (2,700) | 4,600 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 207,300 | 240,400 | 260,300 | 239,100 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $207,300 | $240,400 | $260,300 | $239,100 |
|
0.03% Nasdaq 
0.23%
Income Statement
